Senate panel advances legislation capping private insurance insulin at $35
First publishedJul 22, 20:30 UTC
Last updatedJul 23, 20:27 UTC · 4h ago
1 outlet
The Hill
1 outlets over time — hover a bar for its window & outletslast updated
Answer
Bipartisan legislation to cap the cost of insulin at $35 for people with private health insurance advanced through a key Senate committee Wednesday, but its future remains uncertain. The measure cleared the Senate Health, Education, Labor and Pensions Committee by a bipartisan 17-5 vote, with six Republicans joining every Democrat on the panel.
Reported by 1 outlet — The Hill. See all sources ↓
Read the full report at The Hill ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
In brief
- What's the story?
- Bipartisan legislation to cap the cost of insulin at $35 for people with private health insurance advanced through a key Senate committee Wednesday, but its future remains uncertain. The measure cleared the Senate Health, Education, Labor and Pensions Committee by a bipartisan 17-5 vote, with six Republicans joining every Democrat on the panel.
- How widely is it covered?
- 1 outlet, average source rating 7.0/10.
- When was it last updated?
- 4h ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Senate panel advances legislation capping private insurance insulin at $35
Sources1TypeCoverage
Related in the knowledge graph
organizationBipartisanorganizationDemocratorganizationEducationorganizationLabororganizationPensions CommitteeorganizationRepublicansorganizationSenateorganizationSenate Health
Sources (1)
Avg source rating 7.0/10Processing cluster
A1A2A3B1B2B3